← TEVA PHARMACEUTICAL INDUSTRIES LTD

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value — $963.0m $1.8b $2.0b $2.2b $2.2b $2.8b $3.2b $3.3b $3.6b
Cash and cash equivalents $988.0m — — — — — — — — —
Accounts Receivable $7.5b — — — — — — — — —
Prepaid Expenses $1.4b — — — — — — — — —
Other Current Assets $1.3b — — — — — — — — —
Inventory, Net $5.0b $4.9b $4.7b $4.4b $4.4b $3.8b $3.8b $4.0b $3.0b $3.2b
Assets, Current — $15.4b $13.8b $13.5b $13.0b $12.6b $12.1b $12.5b $12.6b $13.9b
Total current assets $17.0b — — — — — — — — —
Property, Plant and Equipment, Net $8.1b $7.7b $6.9b $6.4b $6.3b $6.0b $5.7b $5.8b $4.6b $4.1b
Goodwill $44.4b $28.4b $24.9b $24.8b $20.6b $20.0b $17.6b $17.2b $15.1b $16.0b
Intangible Assets, Net (Excluding Goodwill) $21.5b — — — — — — — — —
Operating Lease, Right-of-Use Asset — — — $514.0m $559.0m $495.0m $419.0m $397.0m $367.0m $345.0m
Other Assets, Noncurrent — $932.0m $731.0m $591.0m $538.0m $515.0m $441.0m $470.0m $462.0m $405.0m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current — $7.1b $5.8b $5.7b $4.6b $4.5b $3.7b $3.4b $3.1b $3.7b
Deferred Tax Assets, Current $0 — — — — — — — — —
Assets Held For Sale $841.0m — — — — — — — — —
Other Non-Operating Non-Current Assets $1.2b — — — — — — — — —
Deferred Income Taxes $725.0m — — — — — — — — —
Sales reserves and allowances $7.8b — — — — — — — — —
Employee Related Obligations. $859.0m — — — — — — — — —
Liabilities Held For Sale $116.0m — — — — — — — — —
Other Non-Operating Current Liabilities $867.0m — — — — — — — — —
Other taxes and long term liabilities $1.6b — — — — — — — — —
Senior notes and loans $32.5b — — — — — — — — —
Treasury shares ($4.2b) — — — — — — — — —
Stockholders' equity attributable to Teva shareholders $33.3b — — — — — — — — —
Accrued Liabilities, Current $3.4b — — — — $23.0m — — — —
AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax — — — — — — — — — —
Total long term liabilities $39.4b — — — — — — — — —
Total equity $35.0b — — — — — — — — —
Assets — $70.6b $60.7b $57.5b $50.6b $47.7b $44.0b $43.5b $39.3b $40.7b
Total assets $92.9b — — — — — — — — —
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current — — — $435.0m $479.0m $416.0m $349.0m $320.0m $296.0m $288.0m
Accounts Payable, Current $2.2b — — — — — — — $158.0m $225.0m
Operating Lease, Liability, Noncurrent — — — $435.0m $479.0m $416.0m $349.0m $320.0m $296.0m $288.0m
Long-term Debt, Current Maturities — $2.9b $1.7b $1.8b $2.7b $1.4b $2.1b $1.6b $1.8b $1.8b
Short-Term Debt $3.3b — — — — — — — — —
Liabilities, Current — $17.9b $14.3b $13.7b $13.2b $11.0b $11.5b $12.2b $12.8b $13.5b
Total current liabilities $18.5b — — — — — — — — —
Other Liabilities, Noncurrent — $1.8b $1.7b $2.6b $2.2b $2.6b $3.8b $4.0b $4.0b $3.8b
Long-term Debt — — — — — — — — — —
Deferred Tax Liabilities, Non-Current $5.2b — — — — — — — — —
Deferred Tax Liabilities, Net — $2.7b $1.8b $710.0m $269.0m $188.0m ($905.0m) — — —
Liabilities — $51.9b $44.9b $42.4b $39.6b $36.4b $35.3b $35.4b $33.6b $32.8b
Total liabilities $57.9b — — — — — — — — —
Redeemable Noncontrolling Interest, Equity, Carrying Amount — — — — — — — — $340.0m $0
Stockholders’ equity:
Preferred Stock, Value, Issued — $3.6b — — — — — — — —
Common Stock, Value, Issued — $54.0m $56.0m $56.0m $57.0m $57.0m $57.0m $57.0m $58.0m $58.0m
Additional Paid in Capital $23.4b $23.5b $27.2b $27.3b $27.4b $27.6b $27.7b $27.8b $27.8b $28.1b
Retained Earnings (Accumulated Deficit) $13.6b ($3.8b) ($6.0b) ($7.0b) ($10.9b) ($10.5b) ($12.9b) ($13.5b) ($15.2b) ($13.8b)
Accumulated Other Comprehensive Income (Loss), Net of Tax — ($1.9b) ($2.5b) ($2.3b) ($2.4b) ($2.7b) ($2.8b) ($2.7b) ($3.1b) ($2.4b)
Preferred Stock $3.6b — — — — — — — — —
Accumulated other comprehensive income (loss) ($3.2b) — — — — — — — — —
Stockholders' Equity Attributable to Parent — $17.4b $14.7b $14.0b $10.0b $10.3b $7.9b $7.5b $5.4b $7.9b
Stockholders' Equity Attributable to Noncontrolling Interest — $1.4b $1.1b $1.1b $1.0b $966.0m $794.0m $620.0m $7.0m $4.0m
Noncontrolling Interest $1.7b — — — — — — — — —
Total Stockholders' Equity $54.0m — — — — — — — — —
Liabilities and Equity — $70.6b $60.7b $57.5b $50.6b $47.7b $44.0b $43.5b $39.3b $40.7b
Total liabilities and equity $92.9b — — — — — — — — —

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.